Assistant Director of Drug Development

Judy Wang, MD is Lead Author of Manuscript Detailing Investigational Treatment to Improve Immunotherapy Outcomes for Patients with Advanced Cancers

CERo Therapeutics Progresses Phase 1 CER-1236 AML Trial with Dosing of Third Patient in Initial Dose Cohort

Florida Cancer Specialists & Research Institute Clinical Expertise And Real-World Evidence Capabilities Advancing Treatment of Blood Cancers

Veeva MedTech adoption boosts clinical trials

Service Delivery Manager

Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations focused on advancing therapies for cancer patients. The Service Delivery Manager will oversee quality assurance and release management processes across production-based applications, ensuring compliance and minimal risk during releases.

Sign up with Google

Sign in with Google